Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Andrey Gavrilenko"'
Autor:
Andrey Gavrilenko, Vladislav Markelov, Nikita Volkov, Daniil Shmidt, Yaroslav Skiba, Elena Kondakova, Lepik Kirill, Liudmila Fedorova, Marina Popova, Natalya Mikhaylova, Alexander Kulagin
Publikováno v:
HemaSphere, Vol 7, p e49127b4 (2023)
Externí odkaz:
https://doaj.org/article/92005dfa4afc4b2781c7505030294c58
Publikováno v:
Lecture Notes in Networks and Systems ISBN: 9783031110573
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7569cdae898059c22bcd90ab52293c81
https://doi.org/10.1007/978-3-031-11058-0_91
https://doi.org/10.1007/978-3-031-11058-0_91
Autor:
Andrey Gavrilenko, B. V. Afanas’ev, Nataliya Mikhaylova, Yu.R. Zalyalov, Ye. Kondakova, K. Yakimovich, Ivan V. Tsygankov, Aleksey Polushin, Kirill Lepik
Publikováno v:
Problems in oncology. 65:294-297
Despite the progress in the therapy of a primary central nervous system lymphoma (PCNSL) the rates of disease relapse and resistance to therapy are high. Development of new effective therapeutic strategies is needed. One of the key mechanisms in the
Autor:
Yuriy Fadin, Aleksey Gavshin, Yuliya Tyufanova, Svetlana Lozovaya, Leonid Kulakov, Vasiliy Bogdanov, Andrey Gavrilenko
Publikováno v:
Bulletin of Belgorod State Technological University named after. V. G. Shukhov. 2:153-158
Autor:
Kirill V. Lepik, Nikita P. Volkov, Boris V. Afanasyev, E. Kondakova, M. Popova, Aleksandr D. Kulagin, Alexey Polushin, Daniil I. Shmidt, Yuri R. Zalaylov, Andrey Gavrilenko, Natalia B. Mikhailova
Publikováno v:
Blood. 136:4-4
Background.Most patients with primary CNS lymphoma (PCNSL), an aggressive extranodal lymphoma confined to the CNS, have a poor prognosis in spite of development of chemotherapy regimens. First-line treatment consists of high-dose methotrexate-based (
Publikováno v:
Актуальные направления научных исследований XXI века: теория и практика. 3:386-389
Autor:
Elena Vinogradova, Andrey Zaritskiy, Tatyana Schneider, Alexey Maschan, A. D. Kulagin, S.P. Yakupova, Tatiana Krinitsina, T S Kaporskaya, Andrey Gavrilenko, Yulia Bogdanova, Elena Shilova, Bulat Bakirov, Igor A. Lisukov, Svetlana Volkova, Viktoria Ustyantseva, Natalia Kosacheva, Boris V. Afanasyev, Sergey Meresiy, Kudrat Abdulkadyrov, Valentina Ivanova, Alexander Rumyantsev, Tatiana Kazankova, Yuriy V. Shatokhin, Ludmila Anchukova
Publikováno v:
Blood. 124:5163-5163
Background: Paroxysmal nocturnal hemoglobinuria is a rare clonal hematopoietic stem cell disease that can lead to life-threatening complications including thrombotic events (TE), chronic kidney disease (CKD) and pulmonary hypertension. In 2011 the In
Autor:
Valentina Ivanova, Viktoria Ustyantseva, Bulat Bakirov, Alexander Rumyantsev, Tatiana Krinitsina, Natalia Kosacheva, Boris V. Afanasyev, A. D. Kulagin, Tatyana Schneider, Elena Shilova, Kudrat Abdulkadyrov, T S Kaporskaya, Andrey Gavrilenko, Yuriy V. Shatokhin, Svetlana Volkova, Andrey Zaritskiy, Igor Lisukov, Sergey Meresiy, Alexey Maschan, Yulia Bogdanova, Ludmila Anchukova, S.P. Yakupova
Publikováno v:
Blood. 122:4866-4866
Introduction Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematopoietic stem cell disease that can lead to life-threatening complications including thrombotic events (TE), chronic kidney disease (CKD) and pulmonary hypertension. An internation